Compare key investment metrics of 298380 and 한올바이오파마 in real time. Both stocks belong to the 면역항암제 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- By market capitalization, 한올바이오파마 is larger — ₩2.9T vs 298380's ₩550B. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 298380's current price of 90,200원 sits at about 15% of its 52-week range (59,600원–257,500원).
- 한올바이오파마's current price of 55,900원 sits at about 64% of its 52-week range (21,100원–75,500원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 298380 | 한올바이오파마 |
|---|---|---|
| Price | 90,200원 | 55,900원 |
| PBR | 27.96배 | 17.49배 |
| Market Cap | ₩550B | ₩2.9T |
| 52-Week High | 257,500원 | 75,500원 |
| 52-Week Low | 59,600원 | 21,100원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 298380 or 한올바이오파마?
PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share. A lower PER may suggest the stock is undervalued relative to its earnings. Since PER changes with each earnings report, check the real-time comparison table on this page for the latest 298380 and 한올바이오파마 PER values.
What is the dividend yield difference between 298380 and 한올바이오파마?
Dividend yield measures annual dividends as a percentage of the stock price. A higher yield means more cash income per dollar invested. The dividend yields of 298380 and 한올바이오파마 fluctuate with dividend policy changes and stock price movements — check this page's live data for the most current comparison.
How to compare 298380 and 한올바이오파마?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.